Mental Health Clinics in Kilmarnock, VA Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Diana Jamison Lcsw Pllc Clinic - Adult Mental Health Medicare: Medicare Enrolled Practice Location: 25 Office Park Drive, Kilmarnock, VA 22482 Phone: 804-436-9218 Fax: 804-435-6836 |
Janine Snader Lpc Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 235 N Main St, Kilmarnock, VA 22482 Phone: 757-345-8511 Fax: 833-594-5141 |
Northern Neck Life Consultants, Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 25 Office Park Dr Ste 2, Kilmarnock, VA 22482 Phone: 804-356-3008 |
Rappahannock General Hospital Hospital Units - Psychiatric Unit Medicare: Medicare Enrolled Practice Location: 101 Harris Rd, Kilmarnock, VA 22482 Phone: 804-435-8000 Fax: 804-435-8543 |
Oyster Point Psychological, Inc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 48 South Main Street, Kilmarnock, VA 22482 Phone: 804-435-6777 |
Bay Consulting Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 235 N. Main Street, Kilmarnock, VA 22482 Phone: 804-436-7086 Fax: 804-438-8102 |
News Archive
SARS-CoV-2 saliva testing that omits the RNA extraction step
Even as the COVID-19 pandemic progresses throughout the world, the lack of consistent diagnostic testing has been a bugbear, preventing public health control of the spread of infection. A new study by researchers at the University of Illinois Urbana-Champaign and published on the preprint server bioRxiv in June 2020 reports a new testing method that uses saliva, does not require RNA extraction, and can be scaled up quickly and inexpensively.
EpiCept to conduct Phase III study of EpiCept NP-1 for treatment of chemotherapy induced peripheral neuropathy
EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).
Study points to new strategy for AIDS vaccination
A new HIV study shows how competition among the human immune system's T cells allows the virus to escape destruction and eventually develop into full-blown AIDS.
Researchers take a different perspective to mitigate the spread of COVID-19
While earlier research has mostly looked into factors such as fear, perceived risk, age and political views to determine what makes individuals and societies more or less willing to drastically change their lifestyle and support government-imposed strict restrictions, in order to mitigate the spread of the COVID-19 pandemic, psychologists at the University of Zurich Charlotte Kukowski, Katharina Bernecker and Veronika Brandstätter took a different perspective.
› Verified 9 days ago